Clinical Trials Browser

Phase 1/2 × BMS-813160 × 90 days × Clear all

NCT03767582 2026-05-11

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Phase 1/2 Completed

22 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms